tiprankstipranks
TipRanksTop Financial ExpertsInsidersMichael Joseph Golembiewski

Michael Joseph Golembiewski Insider Profile

4 Followers
Michael Joseph Golembiewski, VP Finance, Controller, CAO at Pernix Therapeutics, holds 86.87K shares in Seelos Therapeutics (Ticker: SEEL), holds 0.00 shares in Pernix Therapeutics (Ticker: PTXTQ).
tipranks
Michael Joseph Golembiewski

Michael Joseph Golembiewski
Pernix Therapeutics (PTXTQ)
VP Finance, Controller, CAO

Not Ranked
Michael Joseph Golembiewski has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$29K
100.00%
A breakdown of Michael Joseph Golembiewski's holdings

Insider Roles

Seelos Therapeutics
(SEEL)
CFO
Roles that Michael Joseph Golembiewski holds in companies

Most Profitable Insider Trade

Stock:
Seelos Therapeutics
(SEEL)
Rating:Informative Buy
Date:Dec 01, 2023 - Today
Return:-66.50%
The most profitable trade made by Michael Joseph Golembiewski

Michael Joseph Golembiewski's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
PTXTQ
Pernix Therapeutics
Aug 09, 2017
Uninformative Buy
$0.00
Seelos Therapeutics
Mar 01, 2024
CFO
Uninformative Buy
454.53
$29.36K
List of latest transactions for each holding click on a transaction to see Michael Joseph Golembiewski's performance on stock

Michael Joseph Golembiewski insider profile FAQ

What is the percentage of profitable transactions made by Michael Joseph Golembiewski?
The percentage of profitable transactions made by Michael Joseph Golembiewski is ―.
    What is the average return per transaction made by Michael Joseph Golembiewski?
    The average return per transaction made by Michael Joseph Golembiewski is ―.
      What stocks does Michael Joseph Golembiewski hold?
      Michael Joseph Golembiewski holds: PTXTQ, SEEL stocks.
        What was Michael Joseph Golembiewski’s latest transaction?
        Michael Joseph Golembiewski latest transaction was an Uninformative Buy of $454.53.
          What was Michael Joseph Golembiewski's most profitable transaction?
          Michael Joseph Golembiewski’s most profitable transaction was an Informative Buy of SEEL stock on December 1, 2023. The return on the trade was -66.50%.
            What is Michael Joseph Golembiewski's role in Pernix Therapeutics?
            Michael Joseph Golembiewski's role in Pernix Therapeutics is VP Finance, Controller, CAO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.